A population based study to analyse amyotrophic lateral sclerosis as a multi-step process
- PMID: 40169635
- PMCID: PMC11962139
- DOI: 10.1038/s41598-025-89616-7
A population based study to analyse amyotrophic lateral sclerosis as a multi-step process
Abstract
Recent studies suggest that Amyotrophic Lateral Sclerosis (ALS) follows a multistep process. We evaluated this hypothesis in a well-defined ALS population in Palermo, Sicily, almost entirely followed by our ALS Clinical Center. Incident data from the ALS Center (2014-2023) were analyzed, including both sporadic and familial ALS forms of the disease. To evaluate the multistep process, we regressed the natural log of age-specific incidence against the natural log of patient age We identified 216 ALS patients. We obtained a slope of 5 (r2 = 0.93); the 95% CI ranged from 2.51 to 7.60, remaining relatively wide due to the small sample size, with a p-value of 0.008. The slope estimate was consistent with a 6-step process. In the Palermo ALS population, the multistep analysis confirms a process consistent with a 6-step model. This data, obtained in a relatively homogeneous population, further highlights the probability of strict interaction between environmental and genetic variables in the disease. Our data offer insights into the complexity of the mechanisms involved in the pathogenesis of the disease, particularly during its asymptomatic phase. This study supports the hypothesis that a single therapeutic silver bullet would probably be insufficient to arrest or slow the disease's progression.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: Dr. D’Amico reports no conflict of interest related to this work; Dr. Cucunato reports no conflict of interest related to this work; Prof. Salemi reports no conflict of interest related to this work; Prof. Aridon reports no conflict of interest related to this work.
Figures


References
-
- Kiernan, M. C. et al. Amyotrophic lateral sclerosis. Lancet377, 942–955 (2011). - PubMed
-
- Cellura, E., Spataro, R., Taiello, A. C. & La Bella, V. Factors affecting the diagnostic delay in amyotrophic lateral sclerosis. Clin. Neurol. Neurosurg.114, 550–554 (2012). - PubMed
-
- Mitsumoto, H., Brooks, B. R. & Silani, V. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved? Lancet Neurol.13, 1127–1138 (2014). - PubMed
-
- Salmon, K. & Genge, A. Clinical Trials in ALS – Current Challenges and Strategies for Future Directions. In: Spectrums of Amyotrophic Lateral Sclerosis: Heterogeneity, Pathogenesis, and Therapeutic Directions. 1ST Edition. (Christopher A. Shaw and Jessica R. Morrice, Eds.) Chapt. 9, pg 161–180. John Wiley & Sons Ltd. (2021).
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous